Assistance Listing 93.CRP
21st Century Cures Act: Regenerative Medicine Initiative - Research Projects
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · National Institutes of Health
Assistance Listing 93.CRP, “21st Century Cures Act: Regenerative Medicine Initiative - Research Projects,” is a federal program administered by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. It provides cooperative agreement assistance. GrantsJunction currently tracks 0 open, 0 forecasted and 0 closed opportunities under this listing. The agency reported $914K in obligations for fiscal year 2025.
Program objective
The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA). Regenerative medicine is an emerging area of science that holds great promise for treating and even curing a variety of injuries and diseases. Regenerative medicine includes using stem cells and other technologies—such as engineered biomaterials and gene editing—to repair or replace damaged cells, tissues, or organs. Stem cell-based approaches are under development in labs around the world, and some have already moved into clinical trials. Such progress notwithstanding, much work remains to be done toward the development of safe and effective regenerative medicine products and to realize the full potential of this field.
As published in the SAM.gov Assistance Listing.
Current opportunities under 93.CRP
No open or forecasted opportunities are currently posted under this listing. Programs often post notices on an annual cycle — see recently closed opportunities below for timing.
Eligible applicants (program level)
- Unrestricted by Entity Type
The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that applies and receives a grant for support of research by a named principal investigator. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Reported obligations by fiscal year
Historical data · not a predictionFrequently asked questions
What is ALN 93.CRP?
93.CRP is the Assistance Listing Number for “21st Century Cures Act: Regenerative Medicine Initiative - Research Projects.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
Who can apply under ALN 93.CRP?
The SAM.gov listing names these applicant types: Unrestricted by Entity Type. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
How much funding does 93.CRP provide?
The agency reported $913,996 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.